Current Challenges in Bioequivalence, Quality, and Novel Assessment Technologies for Topical Products

By Yacobi Avraham   Shah Vinod   Bashaw Edward   Benfeldt Eva   Davit Barbara   Ganes Derek   Ghosh Tapash   Kanfer Isadore   Kasting Gerald   Katz Lindsey   Lionberger Robert   Lu Guang   Maibach Howard   Pershing Lynn   Rackley Russell   Raw Andre   Shukla Chinmay   Thakker Kailas   Wagner Nathalie   Zovko Elizabeta   Lane Majella  

Pharmaceutical Research, Vol. 31, Iss. 4, 2014-04 ,pp. : 837-846

Springer Publishing Company

Access to resources Recommend Favorite

Pharmacokinetic analysis of the FDA guidance for industry-'Topical dermatologic corticosteroids: in vivo bioequivalence'

By Leopold C.S.  

European Journal of Pharmaceutics and Biopharmaceutics, Vol. 56, Iss. 1, 2003-07 ,pp. : 53-58

Elsevier

Access to resources Recommend Favorite

Bioequivalence: A Review of Study Design and Statistical Analysis for Orally Administered Products

By Patterson Scott D.  

International Journal of Pharmaceutical Medicine, Vol. 20, Iss. 4, 2006-01 ,pp. : 243-250

Adis International

Access to resources Recommend Favorite

Ablative Fractional Resurfacing in Topical Drug Delivery: An Update and Outlook

By Bloom Bradley S.   Brauer Jeremy A.   Geronemus Roy G.  

Dermatologic Surgery, Vol. 39, Iss. 6, 2013-06 ,pp. : 839-848

Elsevier

Access to resources Recommend Favorite

An Update on Natural Products with Carbonic Anhydrase Inhibitory Activity

By  

Current Pharmaceutical Design, Vol. 22, Iss. 12, 2016-04 ,pp. : 1570-1591

Bentham Science Publishers

Access to resources Recommend Favorite